- Home
- PROK vs MRBK Comparison
PROK vs MRBK Comparison
Compare PROK & MRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- MRBK
- Stock Information
- Founded
- PROK 2015
- MRBK 2004
- Country
- PROK United States
- MRBK United States
- Employees
- PROK N/A
- MRBK N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- MRBK Major Banks
- Sector
- PROK Health Care
- MRBK Finance
- Exchange
- PROK Nasdaq
- MRBK Nasdaq
- Market Cap
- PROK 186.8M
- MRBK 185.1M
- IPO Year
- PROK N/A
- MRBK 2017
- Fundamental
- Price
- PROK $1.05
- MRBK $14.55
- Analyst Decision
- PROK Buy
- MRBK Buy
- Analyst Count
- PROK 5
- MRBK 2
- Target Price
- PROK $4.50
- MRBK $16.00
- AVG Volume (30 Days)
- PROK 546.9K
- MRBK 70.3K
- Earning Date
- PROK 03-21-2025
- MRBK 04-25-2025
- Dividend Yield
- PROK N/A
- MRBK 3.44%
- EPS Growth
- PROK N/A
- MRBK 25.00
- EPS
- PROK N/A
- MRBK 1.45
- Revenue
- PROK N/A
- MRBK $100,936,000.00
- Revenue This Year
- PROK N/A
- MRBK $22.20
- Revenue Next Year
- PROK N/A
- MRBK $9.93
- P/E Ratio
- PROK N/A
- MRBK $10.03
- Revenue Growth
- PROK N/A
- MRBK 7.27
- 52 Week Low
- PROK $0.98
- MRBK $8.26
- 52 Week High
- PROK $4.44
- MRBK $17.33
- Technical
- Relative Strength Index (RSI)
- PROK 23.63
- MRBK 24.82
- Support Level
- PROK $0.98
- MRBK $16.74
- Resistance Level
- PROK $1.32
- MRBK $16.00
- Average True Range (ATR)
- PROK 0.11
- MRBK 0.71
- MACD
- PROK -0.04
- MRBK -0.21
- Stochastic Oscillator
- PROK 10.61
- MRBK 3.15
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.
About MRBK Meridian Corporation
Meridian Corp is a full-service, state-chartered commercial bank providing personal, business lending, and deposit services. It operates in three business segments including Bank, Wealth, and Mortgage. It generates maximum revenue from the Bank segment that consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans, resulting in the generation of net interest income, and other sources.